The relationship between IV indomethacin use and changes in the total serum bilirubin levels of low birth weight neonates
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: LEE, Zon-Min (Kaohsiung Chang Gung Memorial Hospital, Department of Pharmacy, Kaohsiung, China Taiwan)
- Co-author(s): Chen, Fu-An (Department of Pharmacy, Tajen University, Pingtung, Taiwan, Pingtung, China Taiwan)
Lee, Ping-Yu (Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, China Taiwan)
Deng, Shin-Tarng (Chang Gung Memorial Hospital, Linkou, China Taiwan)
Background: Sulfisoxazole and ceftriaxone are known to be contraindicated in neonates with hyperbilirubinemia because of the high protein-binding ability. However, drugs with high protein-binding abilities, such as indomethacin (99 %), are commonly used in low birth weight (LBW) neonates for treatment of patent ductus arteriosus. Aims: The aim of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.